CIK: 1547959 - Address: C/O Mirum Pharmaceuticals, Inc., 989 E Hillsdale Blvd., Suite 300, Foster City, CA 94404
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
9/10/25 17:50
9/8/25
MIRMMirum Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsRamasastry SairaCADM.d40023.510170D
9/10/25 17:50
9/8/25
MIRMMirum Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsRamasastry SairaCADS.d00.000-17-1000D
6/4/25 16:11
6/2/25
MIRMMirum Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsRamasastry SairaCADS.dm-37846.060-8-1000D
6/4/25 16:11
6/3/25
MIRMMirum Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsRamasastry SairaCADM.d3514.12030D
6/2/25 19:46
5/29/25
MIRMMirum Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsRamasastry SairaCADM.d00.0006New6D
6/21/24 19:17
6/21/24
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsRamasastry SairaCADS-13213.190-10-2040D
6/12/24 12:21
6/11/24
VIRVir Biotechnology, Inc.DEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADS-4410.950-4-2115D
6/7/24 18:20
6/5/24
MIRMMirum Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsRamasastry SairaCADM.d7114.12050D
6/7/24 18:20
6/5/24
MIRMMirum Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsRamasastry SairaCADS.d-12825.680-5-1000D
6/2/23 12:19
6/1/23
VIRVir Biotechnology, Inc.DEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADS-9025.670-4-2511D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact